tiprankstipranks
Trending News
More News >
Lipigon Pharmaceuticals AB (DE:9RP)
:9RP

Lipigon Pharmaceuticals AB (9RP) Revenue

Compare
0 Followers

Lipigon Pharmaceuticals AB Revenue

Lipigon Pharmaceuticals AB had a revenue of 0.00 in the quarter ending Sep 30, 2024, with -100.00%. This bring the company's revenue in the last twelve months to 8.97M, Increased -3.83%. In the fiscal year ending Dec 31, 2024, Lipigon Pharmaceuticals AB had annual revenue of 10.29M with -37.30% growth.
Revenue (ttm)
8.97M
Revenue Growth
P/S Ratio
0.48
Revenue/Employee
€1,714,500
Employees
6
Market Cap
€4.90M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
10.29M-6.12M-37.30%
Dec 31, 2023
16.41M16.02M+4,106.92%
Dec 31, 2022
390.00K-2.79M-87.74%
Dec 31, 2021
3.18M-1.10M-25.67%
Dec 31, 2020
4.28M2.54M+145.44%
Dec 31, 2019
1.74M1.73M+9,583.33%
Dec 31, 2018
18.00K+∞%
Dec 31, 2017
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis